Skip to main content

Table 1 Patients and tumor pathological parameters of the studied population

From: Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis

Patients and tumor characteristics TWIST1 marker CD105 marker
Number of CRC samples 223 208
Mean age, years (Range) 59 (20–91) 59 (25–88)
  ≤ Mean age 110 (49.3) 105 (50.5)
  > Mean age 113 (50.7) 103 (49.5)
Gender
 Male 114 (51.1) 111 (53.4)
 Female 109 (48.9) 97 (46.6)
 (Male/Female) 1.04 1.14
Mean tumor size (cm) 5 5
  ≤ Mean 156 (70.0) 145 (69.7)
  > Mean 67 (30.0) 63 (30.3)
Tumor differentiation
 Well 103 (46.2) 89 (42.8)
 Moderate 104 (46.6) 107 (51.4)
 Poor 16 (7.2) 12 (5.8)
TNM stage
 I 40 (17.9) 29 (13.9)
 II 98 (43.9) 92 (44.2)
 III 79 (35.4) 80 (38.5)
 IV 6 (2.7) 7 (3.4)
Vascular invasion (VI)
 Present 36 (16.1) 37 (17.8)
 Absent 187 (83.9) 171 (82.2)
Lymph node invasion (LNI)
 Involved 82 (36.8) 83 (39.9)
 None 141 (63.2) 125 (60.1)
Neural invasion (NI)
 Involved 47 (21.1) 57 (27.4)
 None 176 (78.9) 151 (72.6)
Distant metastasis
 Present 37 (16.6) 30 (14.4)
 Absent 100 (44.8) 90 (43.3)
 Not identified 86 (38.6) 88 (42.3)
Tumor recurrence
 Yes 42 (18.8) 36 (17.3)
 No 95 (42.6) 85 (40.9)
 Not identified 86 (38.6) 87 (41.8)